查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1692121

製藥噴霧乾燥：市場佔有率分析、行業趨勢和統計、成長預測（2025-2030 年）

Pharmaceutical Spray Drying - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 132 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2025 年醫藥噴霧乾燥市場規模為 22 億美元，預計到 2030 年將達到 31.6 億美元，預測期內（2025-2030 年）的複合年成長率為 7.47%。

醫藥噴霧乾燥-市場-IMG1

疫情初期，由於製造流程顯著放緩以及藥品供需受限，嚴重影響了醫藥噴霧乾燥市場的成長。根據一些政府報告，由於新冠肺炎疫情導致活性藥物成分短缺。同樣，根據藥品出口促進委員會 (PHARMEXCIL) 的數據，2021 年，由於對治療愛滋病毒、癌症、癲癇和瘧疾等各種疾病的藥物的需求增加，新冠疫情導致藥品價格大幅上漲。

然而，藥品短缺的恢復以及 COVID-19 藥物、製藥應用和疫苗中藥物噴霧乾燥的使用增加，對市場產生了積極影響。例如，根據 2023 年 2 月發表的一項題為「噴霧凍乾氯硝柳胺奈米晶體嵌入乾粉用於高劑量肺部輸送」的研究，氯硝柳胺 (NCL) 已顯示出在 COVID-19 治療中的潛在應用。然而，開發有效輸送氯硝柳胺（NCL）的新配方仍然是一項挑戰。在此背景下，採用新穎的噴霧冷凍乾燥技術製備了含氯硝柳胺的吸入乾粉（NeDPI），使藥物輸送更加容易。

這些案例表明，市場最初由於供應鏈中斷而經歷了成長放緩。然而，隨著供不應求的恢復以及 COVID-19 藥物和疫苗的藥物噴霧乾燥使用量的增加，市場在疫情期間受到了積極影響，預計在預測期內將繼續呈現上升趨勢。

慢性病盛行率的上升、技術進步、產品穩定性的提高以及研發支出的增加是推動市場發展的關鍵因素。

根據 PharmTech 2022 年 2 月的期刊出版物，生物製藥的不斷發展推動了對噴霧乾燥的需求，作為生物製藥製造和加工的替代方案，而不是傳統的液體或冷凍乾燥固體形式。新的藥物噴霧乾燥方法可以更好地控制所生產粉末的特性，為下游製程提供顯著優勢。透過適當的製程開發，噴霧乾燥還可以直接壓縮無定形固體分散體（ASD）製劑，避免了壓片前製粒的需要。由於這些技術進步，大多數製藥公司現在都採用噴霧乾燥而不是傳統方法。

此外，慢性病的增加也推動了市場的成長。例如，根據國際糖尿病聯盟2021年發布的資料，全球約有5.37億成年人患有糖尿病，預計2030年將有約6.43億人患有糖尿病。另外，有報告指出，每四名成年人中就有三人患有糖尿病，每兩名成年人中就有一人（2.4億人）患有未確診的糖尿病。同樣，根據國際糖尿病聯盟 2021 年的報告，超過 120 萬名青少年和兒童患有第 1 型糖尿病。

此外，根據美國癌症協會2023年大腸癌統計數據，預計2023年美國將有超過153,020名成年人被診斷出罹患大腸癌。這些數字包括美國106,970例新發結腸癌病例和46,050例新發直腸癌病例。藥物噴霧乾燥是大多數製藥公司生產高品質藥物的首選技術。慢性病的發展預計將增加對治療慢性病的高品質藥物開發的需求，這也可能增加對噴霧乾燥技術的需求。因此，預計預測期內慢性病的高盛行率將對市場成長產生正面影響。

然而，噴霧乾燥的高成本以及對經驗豐富的操作員的需求可能會在預測期內阻礙市場的成長。

醫藥噴霧乾燥市場的趨勢

預測期內輔料製造領域預計將大幅成長

  • 藥用輔料是除活性藥物成分 (API) 之外，已經過適當的安全評估並有意包含在藥物輸送系統中的物質。乾顆粒是透過噴霧乾燥生產的，即將賦形劑溶解在水或有機溶劑中，然後在高於溶劑汽化點的溫度下，使用壓縮空氣將所得溶液透過細霧化噴嘴噴出。釋放出的細小液滴會迅速乾燥，然後透過旋風機制收集顆粒。粒度由溶液中賦形劑的濃度和施加於氣流的壓力控制。
  • 賦形劑的優勢和日益成長的研究是市場的主要驅動力。輔料在藥物配方中至關重要，因為它們能夠實現藥物輸送，並且可佔藥物配方的 80-90%。對於品牌藥物，使用新型輔料有可能最佳化藥物性能和格式，開發以前無法開發的候選藥物，為患者提供最佳化格式的創新藥物。因此，考慮到這些分子的優勢，製藥公司正在大力投資這些輔料的生產。因此，噴霧乾燥在特殊製造中的應用越來越多，從而促進了該領域的成長。
  • 此外，日益增多的研究活動也有望推動該領域的成長。例如，2021年9月，美國食品藥物管理局（USFDA）啟動了一項新的試驗計畫，以審查用於滿足新藥配方中未滿足的需求的新型輔料。透過該計劃，FDA 旨在加速開發可能有用的輔料，以應對輔料製造商和藥物開發商先前表示現有輔料難以使用的情況。預計這些政府措施將在預測期內促進該行業的成長。
  • 此外，預計在預測期內，藥品需求的增加、輔料生產設施的新投資以及政府推動藥品和其他醫藥產品國內生產的舉措都將推動市場成長。例如，2023 年 6 月，Croda, Inc. 開始在賓州建造新工廠，以提高其藥用輔料的生產能力。據該公司介紹，新工廠將用於生產用於 mRNA 疫苗和基因編輯療法等新型療法的藥物傳輸系統的原料。因此，新的賦形劑製造設施的推出預計將推動對噴霧乾燥機的需求，因為它們是賦形劑製造中必不可少的組件之一。
  • 因此，鑑於噴霧乾燥技術在賦形劑製造中的重要性，預計該技術帶來的優勢和賦形劑製造設施的增加將在預測期內推動該領域成長。

預計北美將在預測期內佔據最大佔有率

  • 由於大型製藥企業的存在、藥品需求量大、技術進步以及醫藥品研究開發費用高等因素，預計北美將佔據主要佔有率。越來越多的公司注重市場擴張，並採取商業策略來保持其在市場中的地位，預計將推動市場成長。
  • 例如，2022年1月，Eurofins（一家合約開發和製造組織）宣佈在北美擴展其現有的噴霧乾燥開發和製造服務。此次擴張進一步補充了 Eurofins 專注於增強臨床開發和小規模商業項目的溶解度的廣泛服務。
  • 慢性病負擔的增加和對藥品研發活動的投資增加是預測期內推動該地區藥品噴霧乾燥市場發展的一些主要促進因素。例如，根據美國癌症協會2022年的報告，2022年全國將報告約190萬例癌症病例，乳癌將成為最常見的癌症形式。
  • 此外，隨著對乾燥藥品的需求不斷增加，該公司正在採用先進的噴霧乾燥技術來提高產量和工作流程。預計此類收購將在預測期內進一步推動美國市場的成長。
  • 例如，2023 年 5 月，為生物製藥行業服務的合約開發和受託製造廠商(CDMO) 和臨床試驗供應服務公司 Experic 宣布將增加噴霧乾燥功能以支持生物製藥配方和開發。
  • 因此，由於慢性病發生率高和原料藥製造設施的投資，預計預測期內北美的醫藥噴霧乾燥市場將會成長。

製藥噴霧乾燥產業概況

由於有各種參與者，醫藥噴霧乾燥市場較為分散。一些領先的公司正在積極尋求與其他公司的收購或合資，以加強其在全球的市場地位。一些佔據市場主導地位的公司包括 GEA Group Aktiengesellschaft、山東天利乾燥設備有限公司、Buchi Labortecknik AG、European SprayDry Technologies 和 Labplant。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第 1 章 簡介

  • 研究假設和市場定義
  • 研究範圍

第2章調查方法

第3章執行摘要

第4章 市場動態

  • 市場概況
  • 市場促進因素
    • 慢性病盛行率不斷上升
    • 技術進步和產品穩定性提高
    • 研發成本增加
  • 市場限制
    • 噴霧乾燥高成本且需要熟練的操作員
  • 波特五力分析
    • 新進入者的威脅
    • 購買者/消費者的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭對手之間的競爭強度

第5章 市場區隔

  • 按應用
    • 輔料製造
    • 封裝
    • 提高生物有效性
    • 其他用途
  • 按地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 其他歐洲國家
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • GCC
      • 南非
      • 其他中東和非洲地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區

第6章 競爭格局

  • 公司簡介
    • GEA Group Aktiengesellschaft
    • SPX Flow
    • PROCEPT
    • Shandong Tianli Energy Co. Ltd
    • BUCHI Labortechnik AG
    • European SprayDry Technologies
    • Labplant
    • New AVM Systech Pvt. Ltd.
    • Advanced Drying Systems
    • Lemar Drying Engineering

第7章 市場機會與未來趨勢

簡介目錄
Product Code: 90725

The Pharmaceutical Spray Drying Market size is estimated at USD 2.20 billion in 2025, and is expected to reach USD 3.16 billion by 2030, at a CAGR of 7.47% during the forecast period (2025-2030).

Pharmaceutical Spray Drying - Market - IMG1

The initial phase of the pandemic has had a substantial impact on the growth of the pharmaceutical spray drying market owing to the significant decline in manufacturing processes and restricted demand and supply of drugs. The government of several countries has reported that active pharmaceutical ingredients are in short supply because of the COVID-19 pandemic. Likewise, according to the Pharmaceutical Export Promotion Council (PHARMEXCIL), in 2021, the COVID-19 pandemic resulted in a massive spike in medicine prices due to increased demand for drugs to treat a variety of diseases, including HIV, cancer, epilepsy, and malaria.

However, the recovery from the shortage and increasing use of pharmaceutical spray drying for COVID-19 drugs, drug applications, and vaccines have positively impacted the market. For instance, according to the study titled, 'Spray freeze-dried niclosamidenanocrystals embedded dry powder for high dose pulmonary delivery,' published in February 2023, niclosamide(NCL) has shown potential applications for treating COVID-19. However, the development of new formulations for effective niclosamide(NCL) delivery is still challenging. In such cases, niclosamide-embedded dry powder for inhalation (NeDPI) was fabricated by a novel spray freeze-drying technology, making it easier for drug delivery.

Therefore, such instances indicate that the market initially witnessed slow growth owing to supply chain disruption. However, with the recovery from shortage and increasing use of pharmaceutical spray drying for COVID-19 drugs and vaccines, the market witnessed a positive impact during the pandemic and is expected to continue the upward trend over the forecast period.

The increasing prevalence of chronic diseases, technological advancements, improvements in the stability of products, and increasing research and development spending are the major factors propelling market growth.

According to the journal published in February 2022 by PharmTech, the increased development of biologic-based drugs has fueled the demand for spray drying as an alternative for the manufacturing and processing of biologics instead of the more traditional liquid or lyophilized solid forms. The new pharmaceutical spray drying methods offer remarkable control over the properties of the manufactured powders, with significant downstream advantages. With adequate process development, spray drying can also enable amorphous solid dispersion (ASDs) formulations that are directly compressible, thus bypassing the need for granulation prior to tableting. Thus, owing to such technological advancements, the majority of pharmaceutical companies are adopting spray drying over traditional methods.

In addition, increasing cases of chronic diseases are also propelling market growth. For instance, according to the data published by the International Diabetes Federation in 2021, around 537.0 million adults are living with diabetes, and by 2030, around 643.0 million people are expected to live with diabetes. It also reported that 3 out of 4 adults live with diabetes, and around 1 out of 2 adults (240.0 million) are living with undiagnosed diabetes. Similarly, according to the report published by the International Diabetes Federation in 2021, more than 1.2 million adolescents and children are living with type 1 diabetes.

Furthermore, according to the American Cancer Society Colorectal Cancer Statistics in 2023, over 153,020 adults are estimated to be diagnosed with colorectal cancer in 2023 in the United States. These numbers include 106,970 new cases of colon cancer and 46,050 new cases of rectal cancer in the United States, as pharmaceutical spray drying is a technique preferred by most pharmaceutical companies to produce quality drugs. Increasing cases of chronic diseases are anticipated to boost the demand for quality drug development for treatment, which in turn may boost the demand for spray-drying techniques. Thus, the high prevalence of chronic diseases is expected to positively impact the market growth over the forecast period.

However, the high cost associated with spray drying and the requirement of experienced operators is likely to hinder the market growth over the forecast period.

Pharmaceutical Spray Drying Market Trends

Excipient Production Segment is Expected to Witness Considerable Growth Over the Forecast Period

  • Pharmaceutical excipients are substances other than the active pharmaceutical ingredient (API) that have been appropriately evaluated for safety and are intentionally included in a drug delivery system. Manufacturing dry particles by the spray-drying method proceeds in such a way that excipients are dissolved in aqueous or organic solvents, after which the solution thus obtained is sprayed through a narrow atomization nozzle with high pressurized air at a temperature higher than the vaporization point of the solvent. The fine droplets thus emitted are quickly dried, followed by a collection of particles generated by a cyclone mechanism. The particle size is regulated by the concentration of excipients in the solution and the pressure given to the airflow.
  • The advantages of excipients and increasing research work are the major drivers for the market. Excipients are essential to the formulation of drug products because they enable the effective delivery of drug substances and can account for as much as 80-90% of the drug product formulation. For branded drugs, novel excipients could be used to optimize drug product performance and presentation and possibly develop candidates that were deemed undevelopable, leading to transformative medicines with optimized patient presentations. Hence, considering the advantages of these molecules, pharmaceutical companies are investing huge amounts in manufacturing these excipients; therefore, there is increasing use of spray drying for the exception production, posting the segment growth.
  • In addition, increasing research work is also anticipated to propel the segment growth. For instance, in September 2021, the UInted States Food and Drug Administration (USFDA launched a new pilot program to review novel excipients for use in meeting unmet needs in formulating new drug products. Through this program, the FDA intends to raise the development of excipients that may be useful in scenarios where excipient manufacturers and drug developers have cited prior difficulty in using existing excipients. Such initiatives by the government are expected to boost segment growth over the forecast period.
  • Additionally, the rising demand for pharmaceuticals, new investments in the facilities for excipient production, and government initiatives to promote domestic manufacturing of drugs and other pharmaceutical products are expected to boost the market's growth over the forecast period. For instance, in June 2023, Croda, Inc. started constructing its new Pennsylvania facility to enhance its pharmaceutical excipients manufacturing capacity. As per the company, the new facility will be involved in manufacturing ingredients for drug delivery systems used in novel therapeutic drugs such as mRNA vaccines and gene editing therapies. Hence, the launch of new excipient manufacturing facilities is expected to boost the demand for spray dryers as they are one of the essential components for excipient production.
  • Therefore, owing to the enormous significance of the spray drying technique in excipient production, the advantages offered by this technique and an increasing number of excipient manufacturing facilities are expected to boost segment growth over the forecast period.

North America is Expected to held Largest Share Over the Forecast Period

  • North America is anticipated to have a significant share owing to factors such as the presence of major pharmaceutical players, high demand for pharmaceutical products, technological advancement, and high pharmaceutical research and development expenditure in the region. The increasing company focus on expansion and adopting business strategies to withhold their position in the market is likely to boost the growth of the market.
  • For instance, in January 2022, Eurofins (Contract Development and Manufacturing Organization) announced the expansion of its existing spray dry development and production services in North America. With this expansion, Eurofins can further complement a broad range of services specializing in solubility enhancement for clinical development and small-scale commercial programs.
  • The increasing burden of chronic diseases and increasing investment in pharmaceutical research and development activities are some of the major driving factors that are expected to drive the pharmaceutical spray drying market in the region over the forecast period. For instance, according to the 2022 report of the American Cancer Society, about 1.9 million cases of cancer were reported in the country in 2022, with breast cancer being the most prevalent form of cancer.
  • Moreover, with the rising demand for dried pharmaceutical products, companies are acquiring advanced spray-drying technologies to enhance their production and workflow. Such acquisitions are further expected to boost the market's growth in the United States over the forecast period.
  • For instance, in May 2023, Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, announced the addition of spray drying capabilities to support the formulation and development of biopharmaceuticals.
  • Therefore, owing to the high prevalence of chronic diseases and investment in active pharmaceutical ingredient manufacturing facilities, the pharmaceutical spray drying market is expected to grow in North America over the forecast period.

Pharmaceutical Spray Drying Industry Overview

The pharmaceutical spray drying market is fragmented due to the presence of various players in the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions across the globe. Some of the players who are dominating the market are GEA Group Aktiengesellschaft, Shandong Tianli Drying Equipment Corporation Ltd, Buchi Labortecknik AG, European SprayDry Technologies, and Labplant, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases
    • 4.2.2 Technological Advancements and Improvements in the Stability of Products
    • 4.2.3 Increasing Research and Development Spending
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with Spray Drying and Requirement of Experienced Operators
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Application
    • 5.1.1 Excipient Production
    • 5.1.2 Encapsulation
    • 5.1.3 Enhancing Bioavailability
    • 5.1.4 Other Applications
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GEA Group Aktiengesellschaft
    • 6.1.2 SPX Flow
    • 6.1.3 PROCEPT
    • 6.1.4 Shandong Tianli Energy Co. Ltd
    • 6.1.5 BUCHI Labortechnik AG
    • 6.1.6 European SprayDry Technologies
    • 6.1.7 Labplant
    • 6.1.8 New AVM Systech Pvt. Ltd.
    • 6.1.9 Advanced Drying Systems
    • 6.1.10 Lemar Drying Engineering

7 MARKET OPPORTUNITIES AND FUTURE TRENDS